Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease

Nature Medicine

Volumn 10, Issue 4, 2004, Pages 363-364

  Torres, Vicente E ^a   Wang, Xiaofang ^a   Qian, Qi ^a   Somlo, Stefan ^b   Harris, Peter C ^a   Gattone II, Vincent H ^c  

^a Mayo Clinic   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 2; CYCLIC AMP; MOZAVAPTAN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; DRUG TOLERABILITY; ELECTROLYTE DISTURBANCE; KIDNEY CYST; KIDNEY FUNCTION; KIDNEY MASS; KIDNEY POLYCYSTIC DISEASE; KIDNEY PROXIMAL TUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; URINE OSMOLALITY; URINE VOLUME;

ANIMALS; BENZAZEPINES; CYCLIC AMP; DISEASE MODELS, ANIMAL; MICE; PHENOTYPE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; RECEPTORS, VASOPRESSIN;

ANIMALIA;

EID: 1942486801     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1004     Document Type: Article

References (14)

1. Koulen, P. et al. Nat. Cell Biol. 4, 191-197 (2002).
2. Nauli, S.M. et al. Nat. Genet. 33, 129-137 (2003).
3. Qian, Q. et al. Hum. Mol. Genet. 12, 1875-1880 (2003).
4. Chabardes, D., Imbert-Teboul, M. & Elalouf, J.M. Cell. Signal. 11, 651-663 (1999).
5. Wallace, D.P., Rome, L.A., Sullivan, L.P. & Grantham, J.J. Am. J. Physiol. Renal Physiol. 280, F1019-F1029 (2001).
6. Ye, M. & Grantham, J. N. Engl. J. Med. 329, 310-313 (1993).
7. Yamaguchi, T. et al. Kidney Int. 57, 1460-1471 (2000).
8. Gattone, V.H., Wang. X., Harris, P.C. & Torres, V.E. Nat. Med. 9, 1323-1326 (2003).
9. Wu, G. et al. Cell 93, 177-188 (1998).
10. Verani, R.R. & Silva, F.G. Mod. Pathol. 1, 457-463 (1988).
11. Gabow, P. et al. Kidney Int. 35, 675-680 (1989).
12. Sweeney, W.E., Jr. et al. Am. J. Physiol. Cell Physiol. 281, C1695-C1705 (2001).
13. Yamaguchi, T., Wallace, D.P., Grantham, J.J. & Calvet, J.P. J. Am. Soc. Nephrol. 13, 105A (2002).
14. Thibonnier, M., Coles, P., Thibonnier, A. & Shoham, M. Annu. Rev. Pharmacol. Toxicol. 41, 175-202 (2001).